Home | Business News | Browse by Publication | B | Business Wire

Bradmer Pharmaceuticals Inc. Completes Initial Public Offering.

Publication: Business Wire
Publication Date: 22-SEP-05
Format: Online - approximately 375 words
Delivery: Immediate Online Access

Article Excerpt
TORONTO -- Bradmer Pharmaceuticals Inc. (TSX VENTURE:BMR.P) is pleased to announce that it has completed an initial public offering in Alberta and Ontario of 2,500,000 common shares at a price of $0.20 per share for gross proceeds of $500,000. Following the closing of the offering, a total of 7,500,000 common shares of Bradmer Pharmaceuticals were...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Business Wire
Stem Cell Therapy International Engages Auditors Pender Newkirk & Co., September 23, 2005
Akamai to Hold Third Quarter Investor Conference Call on Tuesday, Octo..., September 23, 2005
Nano Chemical Announces Successful Testing of New Product., September 23, 2005
GlaxoSmithKline Continues Power Play in Hot Global Vaccine Market with..., September 23, 2005
Iron and Steel Defy Gravity Predictions as Asian Steelmakers Plot New ..., September 23, 2005

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.